<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02567071</url>
  </required_header>
  <id_info>
    <org_study_id>C14-70</org_study_id>
    <secondary_id>2015-A00586-43</secondary_id>
    <nct_id>NCT02567071</nct_id>
  </id_info>
  <brief_title>Natural Microbiota Restoration After C-section Birth</brief_title>
  <acronym>RESTORE</acronym>
  <official_title>Retablissement Du Microbiote Naturel Apres Naissance Par Cesarienne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proportion of cesarean deliveries reached 30% of births in the US in 2008, while in the
      1970s, it rarely reached 15%, as recommended by WHO. According to recent reports in some
      hospitals in China the use of cesarean section increased from 5% in the 1970s to over 60%.
      The use of C-section continues to grow in every countries of the world despite that current
      knowledge leads us to think that the vaginal birth, retained through millennia during
      mammalian evolution, guarantees the implementation of the best suited intestinal microbiota
      to build immunity and beneficial protective functions under the balanced mutual association
      between the host and its microbiota. Oral administration of a previously impregnated swab, by
      vaginal and maternal perineal secretions, following birth by planned C-section, would restore
      the normal development of the newborn intestinal microbiota mimicking exposure to these
      secretions during vaginal delivery.

      The expected benefit is the establishment of a rich and diverse microbiota in individuals in
      the intervention group and by extension improving the overall health of these individuals.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diversity of the intestinal microbiota</measure>
    <time_frame>1 year</time_frame>
    <description>Intestinal microbiota diversity will be evluated through metagenomics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health status</measure>
    <time_frame>1 year</time_frame>
    <description>Health status of the newborn will be evaluated through questionnaries.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Insufficient Intestinal Microbiota Diversity After C-section Birth</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>75 children born by planned C-section will be exposed to the perineal microbiota of their mothers through perineal impregnated swab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>75 children born by planned C-section will be exposed to clean swab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>75 children born vaginally.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>perineal impregnated swab</intervention_name>
    <description>After planned C-section birth, newborns will suck on previously impregnated swab by perineal and vaginal mother secretions.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>clean swab</intervention_name>
    <description>After planned C-section birth, newborns will suck on clean swab.</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over the age of legal majority

          -  delivery by planned C-section at term or vaginal delivery at term

          -  registered at a social security service

        Exclusion Criteria:

          -  HIV or other STD patients

          -  immunocompromised patients

          -  known streptococcus B carriers

          -  known vaginal or perineal herpes infections

          -  chronic disease patients (obesity, diabetes, IBD)

          -  IMC before pregnancy &gt; 30 kg/m²

          -  antibiotic treatments one month before delivery

          -  emergency C-section

          -  Premature delivery (&lt;37 amenorrhea weeks)

          -  hospitalized for more than one week before delivery

          -  known HVC infections

          -  for the newborns: every diagnosed anomaly

          -  patients who do not understand the research procedures or those that are
             institutionalized, or those unable to give informed consent

          -  patients deprived of ther liberty by legal or administrative decisions

          -  patients under an exclusion period from another study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacky Nizard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacky Nizard, MD, PhD</last_name>
    <email>jacky.nizard@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ludovic Le Chat, PhD</last_name>
    <email>l.le-chat@ican-institute.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Gynécologie-Obstétrique, Groupe Hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacky Nizard, MD, PhD</last_name>
      <email>jacky.nizard@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jacky Nizard, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>September 30, 2015</last_update_submitted>
  <last_update_submitted_qc>September 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>C-section</keyword>
  <keyword>Microbiota</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

